- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Medi Assist reported a strong Q3 & 9MFY26, with consolidated revenue up 24.0% YoY to ₹662.8 Cr for 9MFY26. EBITDA margin expanded by 154 bps QoQ to 19.1%. Premium under Management surged 21.9% YoY to ₹19,298.1 Cr, expanding overall market share to 21.1%. Adjusted Profit After Tax for 9MFY26 was ₹46.3 Cr.
The company's strategy focuses on its AI-powered technology to drive efficiency and scale. Key growth drivers include the successful integration of Paramount, with technology migration on track and AI capabilities enabled for clients. Innovations like MAven Guard identified ~₹400 Cr in fraud, enhancing outcomes.
Recent developments include achieving a debt-free balance sheet by January 2026, significantly reducing prior debt. They also launched MAgnum, a new digital platform for hospitals, and Raksha Prime, which enables over 35,000 bill-free patient discharges monthly. Management is focused on scaling innovation and operational execution for resilient, profitable growth.
All announcements from Medi Assist Healthcare Services Limited